Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Bioinformatics Platform Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The bioinformatics platform market has demonstrated substantial growth in recent years. The market is expected to expand from $10.44 billion in 2025 to $11.27 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.9%. Factors contributing to its historical growth include the increase in genomic sequencing projects, the widening scope of life science research, the development of early bioinformatics tools, enhanced academic research collaboration, and the growing complexity of biological data.
The bioinformatics platform market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $15.19 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.8%. Key factors driving this growth during the forecast period include the increasing adoption of precision medicine, the integration of AI within bioinformatics, the expansion of pharmaceutical R&D efforts, the widespread use of cloud computing in research, and a heightened demand for accelerated drug discovery processes. Prominent trends identified for this period encompass cloud based bioinformatics platforms, AI driven genomic analysis, integrated multi omics data platforms, collaborative research data ecosystems, and automated bioinformatics workflows.
Get A Free Sample Report With In-Depth Market Insights:
Bioinformatics Platform Market Growth Backed By Core Demand Fundamentals
The bioinformatics platform market is anticipated to experience growth in the upcoming years, driven by the increasing adoption of personalized medicine. This healthcare approach customizes treatment and prevention strategies based on an individual’s specific genetic profile, lifestyle choices, and environmental influences. The demand for personalized medicine is on the rise due to advancements in genomic technologies, which facilitate the precise identification of genetic variations linked to diseases, enabling more targeted and effective treatments. This growing demand for personalized medicine necessitates advanced bioinformatics platforms, as they are crucial for analyzing and interpreting vast amounts of genomic and clinical data required for developing individualized treatment plans. For instance, in February 2024, the US-based non-profit organization, Personalized Medicine Coalition (PMC), reported that the FDA authorized 16 new personalized therapies for patients with rare diseases in 2023, a significant rise from the six approvals granted in 2022. Therefore, the expanding integration of personalized medicines will boost the growth of the bioinformatics platform market.
Bioinformatics Platform Market Breakdown By Product Type And Application
The bioinformatics platform market covered in this report is segmented –
1) By Platform Type: Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms, Structural And Functional Analysis Platforms, Other Platforms
2) By Application: Genomics, Proteomics, Drug Discovery, Personalized Medicine, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Healthcare Providers, Other End Users
Subsegments:
1) By Sequence Analysis Platforms: Whole Genome Sequencing (WGS) Platforms, Targeted Sequencing Platforms, RNA Sequencing Platforms, Metagenomic Sequencing Platforms, Exome Sequencing Platforms
2) By Sequence Alignment Platforms: Global Alignment Tools, Local Alignment Tools, Pairwise Alignment Tools, Multiple Sequence Alignment Tools, Structural Alignment Tools
3) By Sequence Manipulation Platforms: Sequence Assembly Tools, Sequence Editing Tools, Sequence Visualization Tools, Sequence Conversion Tools
4) By Structural And Functional Analysis Platforms: Protein Structure Prediction Tools, Structural Bioinformatics Tools, Functional Annotation Tools, Molecular Docking Platforms, Pathway Analysis Tools
5) By Other Platforms: Data Integration Platforms, Data Visualization Platforms, Bioinformatics Workflow Management Platforms, Cloud-Based Bioinformatics Platforms
Bioinformatics Platform Market Growth Trends Reshaping The Competitive Landscape
Leading companies operating within the bioinformatics platform market are developing technologically advanced solutions, such as multiomic data mapping platforms, to offer accurate insights and a deeper understanding of complex diseases and conditions. Multiomic data mapping platforms are integrated systems designed to analyze and correlate data from various biological layers, including genomics, transcriptomics, proteomics, and metabolomics, thereby providing a comprehensive view of complex biological processes. For instance, in February 2023, BioSkryb Genomics, a US-based biotechnology company, introduced the BaseJumper Bioinformatics Platform. This platform is specifically designed to enhance the ResolveOME system by simplifying large-scale single-cell informatics. It enables the quick organization and mapping of multiomic data (DNA, RNA, and protein) generated by ResolveOME, streamlining the process of data interpretation. Furthermore, the platform features dynamic filtering and a comprehensive suite of visualization tools, allowing researchers from various disciplines to easily analyze and visualize complex datasets.
Bioinformatics Platform Market Company Landscape And Competitive Strategy
Major companies operating in the bioinformatics platform market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Dassault Systèmes SE, Agilent Technologies Inc., Illumina Inc., Wuxi NextCODE, PerkinElmer Inc., Partek Incorporated, Qiagen N.V.,Genedata AG,DNAnexus Inc., Sophia Genetics S.A., Accelrys Inc., DNASTAR Inc., Gene Codes Corporation, BGI Group, Fios Genomics Ltd., Golden Helix Inc., Benchling Inc., Velsera Inc., Seqera Labs, Lifebit Biotech Ltd., Genestack Ltd., Biomatters Ltd., Schrödinger Inc., Chemical Computing Group Inc.
View The Full Bioinformatics Platform Market Report:
Bioinformatics Platform Market Top Region By Revenue And Market Share
North America was the largest region in the bioinformatics platform market in 2025. The regions covered in the bioinformatics platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
